Goji Berry Extract (50% Polysaccharides)
Goji Berry Extract (50% Polysaccharides) is a standardized goji/wolfberry extract from Lycium barbarum, designed for immune-support, antioxidant and functional-food wellness formulas. “50% polysaccharides” means about half of the extract is measured as Lycium barbarum polysaccharides (LBP), a group of complex carbohydrates studied for immunomodulatory and antioxidant-related effects. Standardization is important because polysaccharides are a family of molecules rather than one single compound; the declared 50% marker gives formulators a clearer basis for comparing dosage, product quality and expected support claims.
| Benefit | Typical study dose* | Key human findings | High-quality sources |
|---|---|---|---|
| 1 Immune support (immunomodulation) | Wide variability across products; much of the immune signaling is supported by preclinical LBP research | Human evidence is still developing, while reviews give strong mechanistic and preclinical support for LBP immune-signaling concepts with smaller clinical datasets available. | Immune activities of Lycium polysaccharides (review) |
| 2 Antioxidant & inflammation markers | Varies by study design and form (whole fruit vs extract) | Reviews commonly report antioxidant and anti-inflammatory activity, supporting antioxidant wellness claims when dosage and standardization are clearly controlled. | Goji bioactives & health (review) |
| 3 Metabolic markers (lipids/glucose) — mixed | Varies; outcomes depend on baseline status and product form | Some human studies report improvements in triglycerides and HDL in certain settings, making metabolic-wellness support a useful secondary claim area while keeping endpoints tied to the specific study design. | Lycium barbarum supplementation (systematic review) |
| 4 Eye-health signals — stronger for whole goji berries | Whole berries (food) in clinical trials; benefits may reflect carotenoids (zeaxanthin) more than polysaccharides | Trials using goji berries as a food report increased serum zeaxanthin and macular pigment measures; this is best presented as goji-family eye-health context rather than the main claim for a polysaccharide-focused extract. | Goji berries & macular pigment (clinical trial) |
*Doses vary substantially between whole berries, juice preparations, and extracts. Prefer products with declared standardization and consistent assay; build claims around the declared standardization, dose and finished-product format. See systematic review overview.
Mechanistic highlights
- Pattern‑recognition signaling: LBP are studied for interacting with immune pattern‑recognition pathways and downstream cytokine programs (context‑dependent immunomodulation).
- Oxidative‑stress handling: Preclinical models commonly report reductions in oxidative stress readouts and improved antioxidant enzyme activity consistent with “antioxidant support” signaling.
- Metabolic inflammation axis: Reported effects on lipid/glucose markers may relate to inflammation modulation and gut‑immune crosstalk, but clinical effects are heterogeneous.
Safety & practical use
- Usual supplemental range: 300–1,200 mg/day for standardized extracts (adjust to label and local regulatory guidance).
- Upper-dose tolerance: GI upset can occur at higher intakes; reduce dose if discomfort occurs.
- Drug interactions: Avoid with warfarin/anticoagulants unless supervised (case reports of increased INR). See PubMed.
- Glucose-lowering additivity: If using diabetes medications, monitor glucose closely when adding goji products.
- Allergy risk: Rare allergic reactions have been reported; discontinue if symptoms occur. See PubMed.
- light brown to brown powder
- Room (25-40C)
- 24 Months from manufacturing or testing date.
- 300mg - 1200mg
- 600mg
- 300mg - 1200mg
- 600mg
- Powder mixing for food/beverage (oil‑phase disperse or glycol premix)
- 0.00 - 0.00
Cart
No products